TRANSCEND CAPITAL ADVISORS, LLC – Amicus Therapeutics, Inc. Transaction History
TRANSCEND CAPITAL ADVISORS, LLC portfolio value:
$2.24M
portfolio value
TRANSCEND CAPITAL ADVISORS, LLC quarter portfolio value change:
-2.79%
quarter
Amicus Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +9.62% | 18.87K shares | 138K | $10.44 | 215.06K |
| Q2 2022 | share | Increase | +36.99% | 52.97K shares | 751K | $10.74 | 196.19K |
| Q1 2022 | share | Increase | +0.81% | 1.15K shares | -285K | $9.47 | 143.22K |
| Q4 2021 | share | Decrease | -0.56% | -800 shares | 162K | $11.67 | 142.06K |
| Q3 2021 | share | Increase | +1.28% | 1.8K shares | 119K | $9.55 | 142.86K |
| Q2 2021 | share | Decrease | -2.76% | -4K shares | -74K | $9.64 | 141.06K |
| Q1 2021 | share | Increase | +32.05% | 35.20K shares | -1.10M | $9.88 | 145.06K |
| Q4 2020 | share | Increase | 0.00% | 109.85K shares | 2.53M | $23.09 | 109.85K |